Arrowhead Pharmaceuticals (ARWR) Stock: Why The Price Fell

By Amit Chowdhry ● Feb 4, 2022
  • The stock price of Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) fell by 6.92% in the most recent trading session. This is why it happened.

The stock price of Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) fell by 6.92% in the most recent trading session. Investors responded negatively to the company’s first-quarter results.

Arrowhead Pharmaceuticals reported Q1 EPS of ($0.60), which was $0.15 less than analyst estimates of ($0.45). And the revenue for the quarter came was $27.4 million compared to a consensus estimate of $47.81 million.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.